Investors & Media : on Data Provided by Refinitiv. Minimum 15 minutes delayed. Intra 3 mo. 6 mo. 1 yr. News Releases Intercept to Present at September Investor Conference Sep 03, 2020 New Data from the Interim Analysis of REGENERATE Show that OCA Helped Patients with Liver Fibrosis Due to NASH Achieve Sustained Improvement in Noninvasive Markers of Fibrosis Over Two Years of Treatment Aug 27, 2020 Intercept to Present New NASH and PBC Data at the Digital International Liver Congress™ 2020 Aug 21, 2020 Intercept Pharmaceuticals Reports Second Quarter 2020 Financial Results, Announces Updates to Financial Guidance and Provides Business Update Aug 10, 2020 View all press releases > Recent Events and Presentations Wells Fargo 2020 Virtual Healthcare Conference Sep 9, 2020 at 12:00 PM EDT Q2 2020 Intercept Pharmaceuticals Earnings Call Aug 10, 2020 at 8:30 AM EDT Conference Call Jun 29, 2020 at 8:30 AM EDT Bank of America Merrill Lynch Virtual Global Healthcare Conference May 13, 2020 at 2:20 PM EDT View all events & presentations >
New Data from the Interim Analysis of REGENERATE Show that OCA Helped Patients with Liver Fibrosis Due to NASH Achieve Sustained Improvement in Noninvasive Markers of Fibrosis Over Two Years of Treatment Aug 27, 2020
Intercept to Present New NASH and PBC Data at the Digital International Liver Congress™ 2020 Aug 21, 2020
Intercept Pharmaceuticals Reports Second Quarter 2020 Financial Results, Announces Updates to Financial Guidance and Provides Business Update Aug 10, 2020
